2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …

N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes …

F Cosentino, PJ Grant, V Aboyans… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: New features and the 'Ten …

PJ Grant, F Cosentino - 2019 - academic.oup.com
The prevalence of diabetes continues to increase, with 60 million thought to have diabetes
in Europe in 2017 and predictions of more than 600 million individuals with diabetes …

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and …

Authors/Task Force Members, L Rydén… - European heart …, 2013 - academic.oup.com
ESC Guidelines 3039 administrative staff and by the referees and supervisory committees of
the two organizations. It is our hope that this huge effort has generated guidelines that will …

ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD–summary

Task Force on diabetes, pre-diabetes … - Diabetes and …, 2014 - journals.sagepub.com
This is a summary of the second iteration of the European Society of Cardiology's (ESC)
Guidelines on the management of diabetes mellitus (DM), pre-diabetes, and cardiovascular …

[HTML][HTML] 2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in …

S Seidu, X Cos, S Brunton, SB Harris, SPO Jansson… - Primary Care …, 2022 - Elsevier
Type 2 diabetes and its associated comorbidities are growing more prevalent, and the
complexity of optimising glycaemic control is increasing, especially on the frontlines of …

Report from the 4th cardiovascular outcome trial (CVOT) summit of the diabetes & cardiovascular disease (D&CVD) EASD study group

O Schnell, E Standl, D Catrinoiu, B Itzhak… - Cardiovascular …, 2019 - Springer
Abstract The 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes &
Cardiovascular Disease (D&CVD) EASD Study Group was held in Munich on 25–26 …

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational …

V Gyberg, D De Bacquer, G De Backer… - Cardiovascular …, 2015 - Springer
Background In order to influence every day clinical practice professional organisations issue
management guidelines. Cross-sectional surveys are used to evaluate the implementation …

2021 Guidelines on the management of patients with diabetes. A position of Diabetes Poland

A Araszkiewicz, E Bandurska-Stankiewicz… - Clinical …, 2021 - journals.viamedica.pl
Since 2005, the Diabetes Poland (Polskie Towarzystwo Diabetologiczne, PTD) prepares
and publishes annually its guidelines on the management of diabetic patients. The idea of …

2019 guidelines on the management of diabetic patients: a position of Diabetes Poland

A Araszkiewicz, E Bandurska-Stankiewicz… - Clinical …, 2019 - ruj.uj.edu.pl
Since 2005, the Diabetes Poland (PTD, Polskie Towarzystwo Diabetologiczne) prepares
and publishes annually its guidelines on the management of diabetic patients. The idea of …